Skip to main content
. 2012 Nov 27;11(2):113–126. doi: 10.2165/11591240-000000000-00000

Fig. 2.

Fig. 2

Relative potency of targeted agents in metastatic renal cell carcinoma (mRCC).[32,33,39–45] IC 50 = concentration that produces 50% inhibition; VEGFR = vascular endothelial growth factor receptor. Reproduced from Bellmunt et al.,[33] with permission.